New model aims to capitalize on Canada's world-class strength in regenerative medicine
Industry consortium key
A resurgence of interest in the biotechnology sector could propel the Centre for Commercialization of Regenerative Medicine (CCRM) into the sweet spot as it gears up programs and services aimed at moving key discoveries into the marketplace.
Other stories mentioning these organizations, people and topics
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.